# DESIFOR-EXPAND (MHIF)

> **NCT06804980** · PHASE4 · RECRUITING · sponsor: **Minneapolis Heart Institute Foundation** · enrollment: 100 (estimated)

## Conditions studied

- Statin Therapy
- Statin Adverse Reaction
- Statin

## Interventions

- **DRUG:** Rosuvastatin (Crestor)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06804980
- **Lead sponsor:** Minneapolis Heart Institute Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06804980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06804980, "DESIFOR-EXPAND (MHIF)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06804980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*